📊 LITS Key Takeaways
Is Lite Strategy, Inc. (LITS) a Good Investment?
Lite Strategy operates as a fundamentally broken business with near-zero revenue ($214K) while incurring $55M+ in annual operating losses and burning $8M in cash flow annually. With only 11 months of cash runway at current burn rates and no clear path to profitability, the company faces existential risk unless it achieves significant operational restructuring or capital infusion.
LITS shows negligible revenue with a -100% YoY decline and extremely negative margins, consistent with a development-stage pharma lacking commercial traction. While liquidity is strong (10.04x current ratio) and there is no debt, cash of $8.76M against ongoing operating losses and negative FCF implies a limited runway and likely need for external financing. Until revenue visibility improves or burn moderates, fundamentals remain weak.
Lite Strategy, Inc. Key Strengths (LITS)
- Zero long-term debt provides financial flexibility and eliminates refinancing risk
- Strong liquidity position with 11.5x current ratio and $7.5M cash reserves
- Low liability burden ($952K) relative to asset base of $57.8M
- Very strong liquidity (current ratio 10.04x)
- Debt-free balance sheet with minimal liabilities
- Large equity base relative to liabilities
LITS Stock Risks: Lite Strategy, Inc. Investment Risks
- Revenue collapse to $214K (-100% YoY) indicates complete business failure or pre-revenue pharmaceutical shell with no commercialization
- Operating burn of $8M annually with only ~11 months of cash runway before depletion at current burn rates
- Negative operating cash flow and massive operating losses (-$55.2M) with no demonstrated path to profitability or positive unit economics
- As pharmaceutical company with near-zero revenue, R&D spending likely unmatched by any viable product pipeline
- Negligible revenue and -100% YoY decline
- Large operating losses and deeply negative margins
- Potential dilution from capital raises due to limited cash runway
Key Metrics to Watch
- Quarterly revenue and gross margin trends - critical indicator of any commercial traction
- Monthly operating cash burn rate - determines time to insolvency
- Cash balance and runway remaining - direct measure of survival timeline
- Cash & equivalents (runway)
- Operating cash flow (burn rate)
Lite Strategy, Inc. (LITS) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 11.53x current ratio provides a solid financial cushion.
LITS Profit Margin, ROE & Profitability Analysis
LITS vs Healthcare Sector: How Lite Strategy, Inc. Compares
How Lite Strategy, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Lite Strategy, Inc. Stock Overvalued? LITS Valuation Analysis 2026
Based on fundamental analysis, Lite Strategy, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Lite Strategy, Inc. Balance Sheet: LITS Debt, Cash & Liquidity
LITS Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Lite Strategy, Inc.'s revenue has grown significantly by 126% over the 5-year period, indicating strong business expansion. The most recent EPS of $2.67 reflects profitable operations.
LITS Revenue Growth, EPS Growth & YoY Performance
LITS Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | N/A | -$2.6M | $-0.39 |
| Q2 2025 | N/A | -$2.7M | $-0.40 |
| Q1 2025 | N/A | -$3.6M | $-0.12 |
| Q3 2024 | N/A | -$9.1M | $-1.37 |
| Q2 2024 | N/A | -$6.4M | $-0.96 |
| Q1 2024 | $8.7M | -$16.6M | $-2.49 |
| Q3 2023 | $5.9M | -$8.7M | $-1.31 |
| Q2 2023 | $11.8M | -$6.4M | $-0.05 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Lite Strategy, Inc. Dividends, Buybacks & Capital Allocation
LITS SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Lite Strategy, Inc. (CIK: 0001262104)
📋 Recent SEC Filings
❓ Frequently Asked Questions about LITS
What is the AI rating for LITS?
Lite Strategy, Inc. (LITS) has a Combined AI Grade of C from Claude (D) and ChatGPT (C) with 82% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are LITS's key strengths?
Claude: Zero long-term debt provides financial flexibility and eliminates refinancing risk. Strong liquidity position with 11.5x current ratio and $7.5M cash reserves. ChatGPT: Very strong liquidity (current ratio 10.04x). Debt-free balance sheet with minimal liabilities.
What are the risks of investing in LITS?
Claude: Revenue collapse to $214K (-100% YoY) indicates complete business failure or pre-revenue pharmaceutical shell with no commercialization. Operating burn of $8M annually with only ~11 months of cash runway before depletion at current burn rates. ChatGPT: Negligible revenue and -100% YoY decline. Large operating losses and deeply negative margins.
What is LITS's revenue and growth?
Lite Strategy, Inc. reported revenue of $214.0K.
Does LITS pay dividends?
Lite Strategy, Inc. does not currently pay dividends.
Where can I find LITS SEC filings?
Official SEC filings for Lite Strategy, Inc. (CIK: 0001262104) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is LITS's EPS?
Lite Strategy, Inc. has a diluted EPS of $-1.68.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is LITS's fundamental grade?
Based on our AI fundamental analysis in June 2026, Lite Strategy, Inc. has a C grade with 82% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is LITS stock overvalued or undervalued?
Valuation metrics for LITS: ROE of -102.3% (sector avg: 15%), net margin of -27,164.5% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is LITS's AI grade for 2026?
Our dual AI analysis gives Lite Strategy, Inc. a combined C grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is LITS's free cash flow?
Lite Strategy, Inc.'s operating cash flow is $-8.0M, with capital expenditures of $0.0. FCF margin is -3,718.2%.
How does LITS compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -27,164.5% (avg: 12%), ROE -102.3% (avg: 15%), current ratio 11.53 (avg: 2).